Article
Multidisciplinary Sciences
Huaxia Shi, Ying Xu, Na Tian, Ming Yang, Fu-Sen Liang
Summary: The authors develop a chemically inducible and reversible RNA m6A modification editing platform that allows temporal control at specific sites of individual RNA transcripts.
NATURE COMMUNICATIONS
(2022)
Article
Multidisciplinary Sciences
Geon-Woo Kim, Aleem Siddiqui
Summary: The m(6)A modification of the HCV RNA genome plays a crucial role in IRES-dependent translation, with the m(6)A reader protein YTHDC2 being essential for recognizing and supporting HCV translation initiation. This study highlights the functional significance of m(6)A modification and YTHDC2 in HCV IRES-dependent translation initiation, providing potential therapeutic targets for interfering with the infectious process.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2021)
Article
Biochemistry & Molecular Biology
Zhen Xia, Min Tang, Jiayan Ma, Hongyan Zhang, Ryan C. Gimple, Briana C. Prager, Hongzhen Tang, Chongran Sun, Fuyi Liu, Peng Lin, Yutang Mei, Ruoxin Du, Jeremy N. Rich, Qi Xie
Summary: A bidirectional dCasRx epitranscriptome editing platform was developed to manipulate m6A modifications on RNA transcripts, revealing the molecular function of YTHDF proteins in m6A-mediated mRNA degradation.
NUCLEIC ACIDS RESEARCH
(2021)
Article
Pharmacology & Pharmacy
Wenli Cheng, Min Li, Luyun Zhang, Cheng Zhou, Susu Yu, Xinyue Peng, Wenji Zhang, Wenjuan Zhang
Summary: m6A regulators play a crucial role in the development of NAFLD, with abnormal MYC being identified as a potential therapeutic target.
FRONTIERS IN PHARMACOLOGY
(2022)
Review
Oncology
Nanfang Qu, Xiaotong Bo, Bin Li, Lei Ma, Feng Wang, Qinghua Zheng, Xuhua Xiao, Fengmei Huang, Yuanyuan Shi, Xuemei Zhang
Summary: Liver cancer ranks fifth in terms of incidence worldwide and is the third leading cause of cancer-related deaths. While advancements have been made in treatments such as surgical techniques and immunotherapy, the prognosis for liver cancer patients remains poor. Abnormal expression of m6A-related regulators in HCC has shown potential as diagnostic, prognostic, and therapeutic markers.
FRONTIERS IN ONCOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Dan Yu, Nan Dai, Eric J. Wolf, Ivan R. Correa, Jujun Zhou, Tao Wu, Robert M. Blumenthal, Xing Zhang, Xiaodong Cheng
Summary: PCIF1 is a methyltransferase that can methylate RNA, with a preference for 20-O-methylated nucleotides. It can also methylate uncapped nucleotides, although with lower activity. PCIF1 has opposing activities to the RNA demethylase FTO.
JOURNAL OF BIOLOGICAL CHEMISTRY
(2022)
Article
Oncology
Fan Luo, Kai Lin
Summary: IGF2BP1 is upregulated in gastric cancer and serves as a predictor of poor prognosis for GC patients. Functionally, IGF2BP1 promotes migration and aerobic glycolysis in GC cells. IGF2BP1 interacts with c-MYC mRNA in an m6A-dependent manner to stabilize its stability.
EXPERIMENTAL CELL RESEARCH
(2022)
Review
Pharmacology & Pharmacy
Wenhao Zhu, Renshan Zhao, Xiaomin Guan, Xu Wang
Summary: This review comprehensively analyzes the impact of m(6)A methylation on Prostate cancer, bladder cancer, and renal cell cancer, as well as the relationship between the expression of relevant regulatory factors and their development and occurrence, providing new insights and approaches for the early clinical diagnosis and targeted therapy of urologic malignancies.
FRONTIERS IN PHARMACOLOGY
(2023)
Article
Oncology
Chuan Tan, Yanyan Huang, Zheng Huang, Yuanjia Ning, Lizheng Huang, Xianjian Wu, Yuan Lu, Huamei Wei, Jian Pu
Summary: This study identified that the highly expressed ATP8B1-AS1 in hepatocellular carcinoma (HCC) is modified by N6-methyladenosine (m6A), and this m6A modification increases the transcriptional stability of ATP8B1-AS1, thereby activating MYC gene expression and exerting oncogenic effects in HCC.
JOURNAL OF HEPATOCELLULAR CARCINOMA
(2023)
Article
Biochemistry & Molecular Biology
Yang Guo, Liang Feng
Summary: This study demonstrated that LINC00520 is upregulated in breast cancer and associated with higher tumor grade, poor differentiation, and shorter survival. Functional experiments showed that silencing LINC00520 inhibits breast cancer cell proliferation, migration, and epithelial-mesenchymal transition, as well as tumor growth. Furthermore, LINC00520 expression is regulated by METTL3-mediated m6A modification and acts as a competing endogenous RNA (ceRNA) of miR-577 to increase POSTN expression and activate the ILK/Akt/mTOR pathway.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
(2022)
Article
Multidisciplinary Sciences
Geon-Woo Kim, Jae-Su Moon, Aleem Siddiqui
Summary: This study investigates the functional role of m6A modification in the key events of the HBV life cycle, highlighting the importance of m6A modification in nucleocapsid assembly and RNA-protein interactions. The m6A modification of the 5' epsilon structural element of HBV pgRNA plays a crucial role in viral RNA packaging.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2022)
Article
Biochemistry & Molecular Biology
Lingling Wang, Lujing Wu, Zhouting Zhu, Qiong Zhang, Wanyu Li, Gwendolyn Michelle Gonzalez, Yinsheng Wang, Tariq M. Rana
Summary: PCIF1 is an RNA modification factor that regulates eukaryotic mRNAs. Its upregulation in colorectal cancer (CRC) is associated with poor patient survival. Depletion of PCIF1 inhibits cell migration, invasion, and colony formation in CRC cells, as well as tumor growth in mice. PCIF1 also modulates the response to anti-PD-1 therapy by regulating TGF-beta, IFN-gamma, TNF-alpha, and tumor-infiltrating natural killer cells. Furthermore, PCIF1 directly targets FOS, IFITM3, and STAT1 via m6Am modifications, impacting CRC growth and anti-PD-1 therapy resistance. The inhibition of PCIF1 combined with anti-PD-1 treatment may enhance CRC response to immunotherapy.
Article
Oncology
Di Zhang, DanDan Zhang, Chen Wang, XiaoLi Yang, RongQiang Zhang, Qiang Li, YongMin Xiong
Summary: Lung cancer, the leading cause of death worldwide, requires improved treatment. A study found differential gene expression in lung cancer, with HNRNPC and METTL3 genes being associated with the risk and prognosis of LUAD. These genes can serve as biomarkers for early diagnosis and treatment.
EUROPEAN JOURNAL OF CANCER PREVENTION
(2022)
Article
Biochemistry & Molecular Biology
Wan-Xin Peng, Fei Liu, Jia-Hong Jiang, Hang Yuan, Ziqiang Zhang, Liu Yang, Yin-Yuan Mo
Summary: Accumulating evidence suggests that the N6-methyladenosine (m6A) modification of RNA plays an important role in gene expression regulation, and abnormal mRNA m6A modification is commonly associated with various cancers. However, it is not well understood whether and how m6A modification affects long non-coding RNA (lncRNA) and lncRNA-mediated tumorigenesis, particularly in pancreatic ductal adenocarcinoma (PDAC). In this study, the researchers discovered that an uncharacterized lncRNA called LINC00901 promotes the growth and invasion of pancreatic cancer cells and is subject to m6A modification, which regulates its expression. The study suggests the existence of a LINC00901-IGF2BP2-MYC axis that promotes PDAC progression in an m6A-dependent manner.
Article
Biochemistry & Molecular Biology
Lenka Gahurova, Jana Tomankova, Pavlina Cerna, Pablo Bora, Michaela Kubickova, Giorgio Virnicchi, Kristina Kovacovicova, David Potesil, Pavel Hruska, Zbynek Zdrahal, Martin Anger, Andrej Susor, Alexander W. Bruce
Summary: The early development of preimplantation mouse embryos involves the separation of three blastocyst cell lineages: trophectoderm, primitive endoderm, and epiblast. The separation of the outer trophectoderm lineage from the inner-cell-mass (ICM) lineages starts at the 8- to 16-cell transition and ends at the 32-cell stage. Primary ICM populations are dependent on the temporal activation of mammalian target of Rapamycin (mTOR) during the 8-cell stage, while the inhibition of mTOR leads to compensation by the late blastocyst stage. This mechanism governs the initial spatial segregation of mouse embryo blastomeres and contributes to the segregation of late blastocyst lineages.
Article
Oncology
Karolina Lapinska, Genevieve Housman, Shannon Byler, Sarah Heerboth, Amber Willbanks, Anuja Oza, Sibaji Sarkar
ANTICANCER RESEARCH
(2016)
Review
Biochemistry & Molecular Biology
Mckenna Longacre, Nicole A. Snyder, Genevieve Housman, Meghan Leary, Karolina Lapinska, Sarah Heerboth, Amber Willbanks, Sibaji Sarkar
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2016)
Article
Gastroenterology & Hepatology
Ming Yu, Sean K. Maden, Matthew Stachler, Andrew M. Kaz, Jessica Ayers, Yuna Guo, Kelly T. Carter, Amber Willbanks, Tai J. Heinzerling, Rachele M. O'Leary, Xinsen Xu, Adam Bass, Apoorva K. Chandar, Amitabh Chak, Robin Elliott, Joseph E. Willis, Sanford D. Markowitz, William M. Grady
Article
Oncology
Ting Wang, Sean K. Maden, Georg E. Luebeck, Christopher I. Li, Polly A. Newcomb, Cornelia M. Ulrich, Ji-Hoon E. Joo, Daniel D. Buchanan, Roger L. Milne, Melissa C. Southey, Kelly T. Carter, Amber R. Willbanks, Yanxin Luo, Ming Yu, William M. Grady
CLINICAL EPIGENETICS
(2020)
Article
Genetics & Heredity
Amber Willbanks, Meghan Leary, Molly Greenshields, Camila Tyminski, Sarah Heerboth, Karolina Lapinska, Kathryn Haskins, Sibaji Sarkar
GENETICS & EPIGENETICS
(2016)
Review
Oncology
Sarah Heerboth, Genevieve Housman, Meghan Leary, Mckenna Longacre, Shannon Byler, Karolina Lapinska, Amber Willbanks, Sibaji Sarkar
CLINICAL AND TRANSLATIONAL MEDICINE
(2015)